tradingkey.logo

Hoth Therapeutics Announces Positive Initial Data In Phase 2A Clinical Trial

ReutersApr 15, 2025 1:33 PM

- Hoth Therapeutics Inc HOTH.O:

  • HOTH THERAPEUTICS ANNOUNCES POSITIVE INITIAL DATA IN PHASE 2A CLINICAL TRIAL

  • HOTH THERAPEUTICS INC - PATIENTS EXPERIENCED A 50% REDUCTION IN PRURITUS SEVERITY, WITH MEAN SCORES DROPPING FROM 1.6 ON DAY 1 TO 0.8 BY DAY 21

  • HOTH THERAPEUTICS INC - HT-001 WAS WELL TOLERATED, WITH NO TREATMENT-RELATED SERIOUS ADVERSE EVENTS REPORTED

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI